OncoZenge AB Collaborates with UCLA for BupiZenge™ Patient
17 Sep 2025 //
PR NEWSWIRE
OncoZenge Selects LINK Medical for BupiZenge Phase III Execution
11 Sep 2025 //
PHARMAWEB
OncoZenge AB`s Interim Report: Jan 1 - June 30, 2025
21 Aug 2025 //
PHARMAWEB
OncoZenge Enters SEK 30.2M Investment Agreement With Yangtian
28 Jan 2025 //
PHARMAWEB